CurrentEndo
Get Weekly

Diabetes journalCurrentEndo coverage

Diabetes Technology & Therapeutics

What CurrentEndo has captured from this journal. The coverage figures describe CurrentEndo's coverage, not the journal's output. Figures as of 14 November 2026.

CurrentEndo holds 475 Briefs from Diabetes Technology & Therapeutics, most often cohort studies and other research.

Recent
17 Briefs
past 90 days
Archive
475 Briefs
research published from January 2023 to today
Editorial
–
no Weekly issue published yet

Topics

Evidence types

Shares are of the 475 Briefs CurrentEndo has covered from Diabetes Technol Ther, by primary topic and study type; a Brief without a primary topic is in no topic row.

Publication activity

Latest from Diabetes Technology & Therapeutics

All coverage, newest first

  1. Diabetes Technol Ther

    Assessing the Utility of a Capillary-Adjusted Oral Glucose Tolerance Test for the Early Detection of Type 1 Diabetes in Childhood

    Diagnostic or prognostic studyT1D

  2. Diabetes Technol Ther

    Comparison of Blood Glucose Values Used for Impending Non-Severe Hypoglycemia Management with Corresponding Continuous Glucose Monitoring Data in Type 1 Diabetes: A Secondary Analysis of the REVERSIBLE Trial

    Secondary analysisTechnology

  3. Diabetes Technol Ther

    Exploratory Analysis of Continuous Glucose Monitoring Patterns in First-Degree Relatives with Dysglycemia at Risk of Progression to Stage 3 Type 1 Diabetes

    Secondary analysisTechnology

  4. Diabetes Technol Ther

    Factors Associated with Utilization and Underutilization of Diabetes Technology in Underrepresented Families Living with Type 1 Diabetes

    Cross-sectional studyT1D

  5. Diabetes Technol Ther

    Continuous Glucose Monitoring and Hospitalization Outcomes in Adults with Insulin-Treated Type 2 Diabetes and Complex Care Needs: A Population-Based Study

    Cohort studyTechnology

  6. Diabetes Technol Ther

    Three-Year Real-World Performance of Bihormonal Fully Closed-Loop Therapy in Type 1 Diabetes

    Cohort studyTechnology

  7. Diabetes Technol Ther

    Sustained Glycemic Outcomes with the MiniMed ™ 780G System: Real-World Evidence from >16,000 Users Across 18 Latin American Countries Over Two Years

    Cohort studyT1D

  8. Diabetes Technol Ther

    Association Between Continuous Glucose Monitoring Utilization and Glucagon-Like Peptide-1 Receptor Agonist Discontinuation in Type 2 Diabetes: A Real-World Study

    Cohort studyT2D & other

  9. Diabetes Technol Ther

    Use of Continuous Glucose Monitoring Indicators to Guide Dose Titration of Weekly Basal Insulin Efsitora Alfa in Insulin-Naive and Basal Insulin-Experienced Adults with Type 2 Diabetes: A Retrospective Analysis

    Cohort studyT2D & other

  10. Diabetes Technol Ther

    Continuous Glucose Monitoring Hypoglycemia Alarms in Critical Care: Clinical Utility and Workflow Integration

    Secondary analysisTechnology

  11. Diabetes Technol Ther

    Long-Term Clinical and Economic Impact of Automated Insulin Delivery Systems Use in Pediatric and Adolescents Type 1 Diabetes: Results Across Australia, Canada, the UK, and the USA

    Research articleTechnology

  12. Diabetes Technol Ther

    Pediatric Inpatient Continuous Glucose Monitor Accuracy by Sensor Wear Day, Hospital Day, and Glucose Rate of Change

    Diagnostic or prognostic studyTechnology

  13. Diabetes Technol Ther

    Real-World Data from U.S. Commercial Users of the 365-Day Implantable Eversense Continuous Glucose Monitoring System, Including with the Twiist Automated Insulin Delivery System Integration

    Cohort studyTechnology

  14. Diabetes Technol Ther

    Real-Time Continuous Glucose Monitoring Improves Glycemic Control in the Early Postoperative Period Following Liver Transplantation: A Randomized Controlled Trial

    Randomized controlled trialTechnology

  15. Diabetes Technol Ther

    Natural History of Mild Non-Proliferative Diabetic Retinopathy in Adults with Type 1 Diabetes Under Contemporary Diabetes Care

    Cohort studyComplications

  16. Diabetes Technol Ther

    Determinants of Continuous Glucose Monitoring Accuracy in Critically Ill Patients Requiring Mechanical Ventilation and Vasopressor Support

    Secondary analysisTechnology

  17. Diabetes Technol Ther

    Continuous Glucose Monitoring and Automated Insulin Delivery in Infants with Type 1 Diabetes: Real-World Evidence to Support Future International Guidelines

    Cohort studyTechnology

  18. Diabetes Technol Ther

    CGM Metrics and the Risk of Pregnancy Complications in Type 1 Diabetes: A Secondary Exploratory Analysis of the CRISTAL Trial

    Secondary analysisDiabetes in pregnancy

  19. Diabetes Technol Ther

    Automated Insulin Delivery System Initiation Safely Improves Glycemic Outcomes in Older Adults with Type 1 Diabetes

    Cohort studyTechnology

  20. Diabetes Technol Ther

    Continuous Glucose Monitoring Metrics in Women with Type 2 Diabetes in Pregnancy: The TIMELY Observational Cohort Study

    Cohort studyDiabetes in pregnancy

  21. Diabetes Technol Ther

    Evaluation of an Objective Measure of Mealtime Insulin Administration Frequency in Emerging Adults with Type 1 Diabetes

    Cross-sectional studyTechnology

  22. Diabetes Technol Ther

    Three-Year Durability of Automated Insulin Delivery Therapy in Children and Adolescents with Type 1 Diabetes: A Multicenter Real-World Study

    Cohort studyTechnology

  23. Diabetes Technol Ther

    Use of Low-Glucose Alerts and Their Impact on Continuous Glucose Monitoring Outcomes in Real-World Use of the MiniMed 780G System

    Cohort studyTechnology

  24. Diabetes Technol Ther

    A Simple Meal Bolus Strategy is Effective in Adolescents and Young Adults with Type 1 Diabetes on Multiple Automated Insulin Delivery Systems

    Randomized controlled trialTechnology

  25. Diabetes Technol Ther

    Incident Diabetic Retinopathy after Adjunctive Tirzepatide Treatment for 1 Year in Adults with Type 1 Diabetes

    Cohort studyT1D

  26. Diabetes Technol Ther

    Rebound Hyperglycemia in Children and Adolescents with Type 1 Diabetes Using Automated Insulin Delivery Systems

    Cross-sectional studyTechnology

  27. Diabetes Technol Ther

    Sustained Follow-up of Automated Insulin Delivery in a Real-World Setting: Results at 2 Years of the French Nationwide Observatory OB2F

    Cohort studyTechnology

  28. Diabetes Technol Ther

    A Diabetes Management Protocol with Subcutaneous Insulin During Induced Labor and Delivery in Women with Type 1 or Type 2 Diabetes

    Secondary analysisDiabetes in pregnancy

  29. Diabetes Technol Ther

    Impact of Technology Introduction on Glycemic Control of People Living with Type 1 Diabetes in Belgium: An Observational, Real-World Study

    Cross-sectional studyT1D

  30. Diabetes Technol Ther

    Differences in Achieving Stringent Glycemic Targets Among Youth with Type 1 Diabetes: A SWEET Registry Study

    Cross-sectional studyT1D

  31. Diabetes Technol Ther

    Continuous Glucose Monitoring Metrics and Perinatal Outcomes in Pregnant Women with Type 2 Diabetes

    Cohort studyDiabetes in pregnancy

  32. Diabetes Technol Ther

    Settings Associated with Optimal Glycemic Outcomes with the Omnipod® 5 Automated Insulin Delivery System: Evidence from Real-World Users with Type 1 Diabetes

    Cohort studyTechnology

  33. Diabetes Technol Ther

    Automated Insulin Delivery Systems in Hospitals: A Systematic Review with Meta-Analysis

    Meta-analysisTechnology

  34. Diabetes Technol Ther

    Association Between Longitudinal Time in Range and Albuminuria in Insulin-Treated Diabetes

    Cohort studyTechnology

  35. Diabetes Technol Ther

    Percent Time Below Range Is Strongly Associated with Clinically Important Level 2 Hypoglycemia Events in Individuals with Type 1 Diabetes

    Meta-analysisComplications

  36. Diabetes Technol Ther

    Predicting Risk for Diabetic Ketoacidosis in Children Recently Diagnosed with Type 1 Diabetes Using the Risk Index for Diabetic Ketoacidosis

    Diagnostic or prognostic studyT1D

  37. Diabetes Technol Ther

    Comparative Analysis of Capillary HbA1c and CGM-Derived GMI Estimates: A Real-World Data from a Single Center

    Cohort studyT1D

  38. Diabetes Technol Ther

    Increased Usage of a Diabetes Management App Was Associated with Significant Improvement in Both Glycemic and Non-Glycemic Outcomes for People with Diabetes

    Cohort study

  39. Diabetes Technol Ther

    Engagement with an AI- and CGM-Integrated Digital Health Platform Is Associated with Clinically Significant Weight Loss

    Cohort studyObesity

  40. Diabetes Technol Ther

    Comparing Automated Lyumjev® Delivery with Carbohydrate Counting, Qualitative Meal-Size Estimation, and Fully Closed-Loop in Type 1 Diabetes: A Pilot, Randomized, Crossover Trial

    Randomized controlled trialTechnology

All 475 Briefs in ExploreShowing the 40 most recently published